A Tribute to Scientific Legacy Sets the Stage At the La Sorbonne's 'Choose Europe for Science' event, President Ursula von der Leyen delivered a closing speech emphasizing Europe's enduring commitment to scientific research and innovation. She invoked the pioneering spirit of Marie Curie to illustrate the enduring values of freedom, openness, and collaboration foundational to scientific progress.
The 'Choose Europe Initiative' Von der Leyen outlined a concrete policy framework, termed the "Choose Europe Initiative," with four central pillars aimed at reinforcing Europe's scientific leadership. First, she proposed legally enshrining freedom of scientific research within the forthcoming European Research Area Act, anchoring principles of academic freedom and free exchange of knowledge across the EU. Second, she announced a substantial EUR 500 million funding package for 2025-2027, including enhanced and extended grants via the European Research Council (ERC) to support elite researchers and early career scientists, bolstering Europe's attractiveness as a research hub.
Third, to accelerate the commercialization of scientific breakthroughs, von der Leyen pledged to propose the first European Innovation Act alongside a Startup and Scaleup Strategy aimed at dismantling regulatory hurdles and facilitating venture capital access. Fourth, she emphasized efforts to simplify and expedite entry procedures for top-tier researchers, enhancing linkages between talent and institutions.
Implications and Stakeholder Impact National authorities will be called upon to implement these legislative proposals, potentially increasing administrative responsibilities related to upholding research freedoms and managing funding disbursements. The initiative introduces increased EU influence in the governance of academic research, pointing to a slight shift towards deeper integration in this sector.
For EU scientists and researchers, the initiative offers expanded financial support and career stability, encouraging retention and attraction of talent but also raising expectations concerning compliance and mobility between Member States. Universities and research institutions stand to benefit from enhanced collaboration opportunities and funding. Meanwhile, EU taxpayers underpinning the funding face the long-term prospect of returns from scientific advancements balanced against significant upfront investment and commitment to ambitious R&D spending targets, notably the 3% of GDP goal by 2030.
The proposed ramp-up in innovation support and regulatory easing may favor startups and scaleups in tech-driven industries, fostering competitiveness but potentially intensifying market pressures and demands for compliance. Overall, the initiative reflects a coherent push balancing stronger EU-level coordination and funding with national and institutional responsibilities, aimed at cementing Europe's role as a global scientific leader amid geopolitical and economic complexities.
← Atlas › News › Industry, Innovation and Internal Market